GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » YoY EPS Growth

Voyageur Pharmaceuticals (TSXV:VM) YoY EPS Growth : 33.33% (As of Feb. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Voyageur Pharmaceuticals's YoY EPS Growth for the quarter that ended in Feb. 2024 was 33.33%.

Voyageur Pharmaceuticals's Earnings per Share (Diluted) for the three months ended in Feb. 2024 was C$-0.00.


Voyageur Pharmaceuticals YoY EPS Growth Historical Data

The historical data trend for Voyageur Pharmaceuticals's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals YoY EPS Growth Chart

Voyageur Pharmaceuticals Annual Data
Trend Dec14 Dec15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -100.00 - - 50.00

Voyageur Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.00 - 75.00 100.00 33.33

Voyageur Pharmaceuticals YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Voyageur Pharmaceuticals's YoY EPS Growth for the fiscal year that ended in Nov. 2023 is calculated as:

YoY EPS Growth (A: Nov. 2023 )
=(Earnings per Share (Diluted) (A: Nov. 2023 )-Earnings per Share (Diluted) (A: Nov. 2022 ))/ | Earnings per Share (Diluted) (A: Nov. 2022 ) |
=(-0.01--0.02)/ | -0.02 |
=50.00 %

Voyageur Pharmaceuticals's YoY EPS Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY EPS Growth (Q: Feb. 2024 )
=(Earnings per Share (Diluted) (Q: Feb. 2024 )-Earnings per Share (Diluted) (Q: Feb. 2023 )) / | Earnings per Share (Diluted) (Q: Feb. 2023 )) |
=(-0.002--0.003)/ | -0.003 |
=33.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Voyageur Pharmaceuticals YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Voyageur Pharmaceuticals (TSXV:VM) Business Description

Traded in Other Exchanges
Address
333 Southwest 7th Avenue, Suite 800, Calgary, AB, CAN, T2P 2Z1
Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine-based pharmaceutical products. It provides its products for medical applications and diagnostics.
Executives
Charles Littlejohn 10% Security Holder

Voyageur Pharmaceuticals (TSXV:VM) Headlines

No Headlines